EDGAR Filing Documents for 0001193125-19-066373

Form SC TO-T - Tender offer statement by Third Party:

SEC Accession No. 0001193125-19-066373

Filing Date

2019-03-07

Accepted

2019-03-07 07:53:08

Documents

Group Members

022019 MERGER SUBSIDIARY, INC.

Document Format Files

Seq	Description	Document	Type	Size
1	SC TO-T	d642137dsctot.htm	SC TO-T	33208
2	EX-99.A.1.I	d642137dex99a1i.htm	EX-99.A.1.I	456975
3	EX-99.A.1.II	d642137dex99a1ii.htm	EX-99.A.1.II	196981
4	EX-99.A.1.III	d642137dex99a1iii.htm	EX-99.A.1.III	19670
5	EX-99.A.1.IV	d642137dex99a1iv.htm	EX-99.A.1.IV	18922
6	EX-99.A.1.V	d642137dex99a1v.htm	EX-99.A.1.V	27085
7	EX-99.A.1.VI	d642137dex99a1vi.htm	EX-99.A.1.VI	25685
8	EX-99.(D)(2)	d642137dex99d2.htm	EX-99.(D)(2)	30172
9	GRAPHIC	g642137g05s02.jpg	GRAPHIC	29998
10	GRAPHIC	g642137g22p62.jpg	GRAPHIC	47485
11	GRAPHIC	g642137g85q63.jpg	GRAPHIC	40062
	Complete submission text file	0001193125-19-066373.txt		972744

Mailing Address 1 DNA WAY, MS #24, SOUTH SAN FRANCISCO CA 94080

Business Address C/O THE CORPORATION TRUST, 1209 ORANGE STREET, WILMINGTON, DE 19801 650 225-7893

ROCHE HOLDINGS INC (Filed by) CIK: 0000904566 (see all company filings)

IRS No.: 510304944 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T
SIC: 0000

Mailing Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104

Business Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104 888-772-7560

Spark Therapeutics, Inc. (Subject) CIK: 0001609351 (see all company filings)